Intern - Kite Development - Med Affairs (Strategy and Communications - Cell Therapy)

We’re here for one reason and one reason only – to cure cancer. Every moment is dedicated to developing treatments and every action moves us one step closer to our goal. We’ve made incredible scientific breakthroughs and our pioneering personalized CAR T-cell therapies have changed the paradigm. But we're not finished yet. Join Kite, as we make even bigger advances in cancer therapies, and help shape where our business and medical science goes next. We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Kite and help create more tomorrows.

Job Description

Intern - Kite Development - Med Affairs (Strategy and Communications - Cell Therapy) As a Gilead / Kite intern you will contribute to high-impact meaningful projects that will not only further advance our company’s mission but will allow you to gain real world experience at one of the most innovative organizations in the world. You will also have opportunities to participate in special events including professional development and leadership presentations, social/network building activities and local community volunteer programs. Key Responsibilities will include, but are not limited to the following: Scientific and medical content creation: Support the development of internal and external materials, including slide presentations, literature reviews, and scientific summaries Collaborate with the Strategy Team: Assist in tracking and executing key initiatives and provide coverage for team members when needed Support medical education initiatives: Participate in the planning and coordination of advisory boards, congresses, and webinars, including logistical support and content preparation. Support review and approval of promotiona